Neoplastic lymphomatous submaculopathy

Indian J Ophthalmol. 2019 Dec;67(12):2051-2052. doi: 10.4103/ijo.IJO_1697_19.

Authors

Ilaria Testi¹, Aniruddha Agarwal², Vishali Gupta²; PGI Ocular Lymphoma Study Group

Affiliations

¹ Department of Ophthalmology, University of Padova, Padova, Italy.
² Advanced Eye Center, Department of Ophthalmology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.

No abstract available

Publication types

Case Reports

MeSH terms

Antimetabolites, Antineoplastic / therapeutic use
Female
Fluorescein Angiography
Humans
Intraocular Lymphoma / diagnosis
Intraocular Lymphoma / drug therapy
Intraocular Lymphoma / pathology*
Intravitreal Injections
Lymphoma, Large B-Cell, Diffuse / diagnosis
Lymphoma, Large B-Cell, Diffuse / drug therapy
Lymphoma, Large B-Cell, Diffuse / pathology*
Methotrexate / therapeutic use
Middle Aged
Paraneoplastic Syndromes, Ocular / diagnosis
Paraneoplastic Syndromes, Ocular / drug therapy
Paraneoplastic Syndromes, Ocular / pathology*
Retinal Neoplasms / diagnosis
Retinal Neoplasms / drug therapy
Retinal Neoplasms / pathology*
Tomography, Optical Coherence
Visual Acuity

Substances

Antimetabolites, Antineoplastic
Methotrexate